Effects of Benzpyrene Injection in Rats and Mice
Author Information
Author(s): S. Payne
Primary Institution: Department of Cancer Research, Mount Vernon Hospital and the Radium Institute
Hypothesis
What are the pathological effects of intraperitoneal injection of 3:4-benzpyrene in rats and mice?
Conclusion
Mice are highly susceptible to developing fibrosarcomas after benzpyrene injection, while rats show fewer tumors but significant endocrine changes.
Supporting Evidence
- 73% of mice developed intra-abdominal fibrosarcomata after benzpyrene injection.
- Only one fibrosarcoma was found in the rats, despite significant endocrine changes.
- Repeated injections in female mice reduced the tumor latent period from 33 to 18 weeks.
Takeaway
When scientists injected a chemical called benzpyrene into mice, most of them got tumors, but only one rat did, and the rats had other health problems instead.
Methodology
The study involved injecting benzpyrene into the abdominal cavities of male and female rats and mice, followed by post-mortem examinations to assess tumor development and other pathological changes.
Limitations
The study primarily focused on the immediate pathological effects and did not explore long-term consequences or the effects of different doses.
Participant Demographics
The study included male and female ST. A. strain mice and Wistar strain rats, aged 12 weeks and 6 months respectively.
Want to read the original?
Access the complete publication on the publisher's website